Twin Tree Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39M Sell
29,400
-44,900
-60% -$8.27M 0.11% 206
2025
Q4
$13.1M Buy
74,300
+50,200
+208% +$8.2M 0.11% 222
2025
Q3
$3.38M Buy
24,100
+17,400
+260% +$2.35M 0.01% 889
2025
Q2
$841K Sell
6,700
-3,800
-36% -$473K ﹤0.01% 1382
2025
Q1
$1.44M Buy
10,500
+700
+7% +$100K ﹤0.01% 1208
2024
Q4
$1.5M Sell
9,800
-3,200
-25% -$540K ﹤0.01% 1211
2024
Q3
$2.52M Buy
+13,000
New +$2.72M ﹤0.01% 1086
2024
Q2
Sell
-7,000
Closed -$1.51M 1350
2024
Q1
$1.51M Sell
7,000
-24,400
-78% -$5.71M ﹤0.01% 1020
2023
Q4
$8.13M Buy
+31,400
New +$7.71M 0.02% 746
2023
Q2
Sell
-39,000
Closed -$10.8M 1253
2023
Q1
$10.8M Sell
39,000
-181,200
-82% -$50.1M 0.02% 557
2022
Q4
$61M Sell
220,200
-2,500
-1% -$706K 0.13% 141
2022
Q3
$59.5M Sell
222,700
-129,300
-37% -$27.5M 0.11% 148
2022
Q2
$71.8M Buy
352,000
+257,300
+272% +$52.6M 0.11% 119
2022
Q1
$19.9M Buy
94,700
+48,500
+105% +$10.5M 0.03% 464
2021
Q4
$11.1M Sell
46,200
-7,500
-14% -$1.93M 0.02% 598
2021
Q3
$15.2M Buy
53,700
+3,300
+7% +$1.08M 0.03% 454
2021
Q2
$17.5M Sell
50,400
-17,200
-25% -$5.21M 0.05% 366
2021
Q1
$18.9M Hold
67,600
0.07% 290
2020
Q4
$16.6M Sell
67,600
-251,000
-79% -$64.8M 0.07% 321
2020
Q3
$90.4M Buy
318,600
+20,200
+7% +$5.63M 0.37% 48
2020
Q2
$79.8M Buy
298,400
+96,200
+48% +$28.9M 0.32% 50
2020
Q1
$64M Buy
202,200
+73,100
+57% +$22.2M 0.31% 47
2019
Q4
$38.3M Sell
129,100
-152,600
-54% -$42.3M 0.13% 129
2019
Q3
$65.6M Sell
281,700
-9,100
-3% -$2.12M 0.26% 59
2019
Q2
$68M Sell
290,800
-28,500
-9% -$6.58M 0.33% 51
2019
Q1
$75.5M Buy
319,300
+223,700
+234% +$70.4M 0.39% 48
2018
Q4
$28.8M Sell
95,600
-37,800
-28% -$12.1M 0.18% 97
2018
Q3
$47.1M Buy
133,400
+43,500
+48% +$15M 0.32% 48
2018
Q2
$26.1M Hold
89,900
0.16% 115
2018
Q1
$24.6M Buy
89,900
+53,200
+145% +$16.5M 0.2% 76
2017
Q4
$11.7M Sell
36,700
-9,100
-20% -$2.92M 0.09% 203
2017
Q3
$14.3M Sell
45,800
-97,700
-68% -$28.9M 0.11% 175
2017
Q2
$38.9M Buy
+143,500
New +$37.9M 0.3% 62
2017
Q1
Sell
-59,400
Closed -$16.8M 1017
2016
Q4
$16.8M Buy
59,400
+11,900
+25% +$3.53M 0.16% 147
2016
Q3
$14.9M Sell
47,500
-4,600
-9% -$1.36M 0.19% 111
2016
Q2
$12.6M Buy
52,100
+28,200
+118% +$7.43M 0.2% 106
2016
Q1
$6.22M Sell
23,900
-56,200
-70% -$14.8M 0.12% 187
2015
Q4
$24.5M Buy
80,100
+20,900
+35% +$6.01M 0.49% 19
2015
Q3
$17.3M Buy
59,200
+12,600
+27% +$4.16M 0.44% 20
2015
Q2
$18.8M Sell
46,600
-3,900
-8% -$1.57M 0.46% 27
2015
Q1
$21.3M Buy
50,500
+13,400
+36% +$5.28M 0.55% 19
2014
Q4
$12.6M Sell
37,100
-6,400
-15% -$2.07M 0.35% 44
2014
Q3
$14.4M Sell
43,500
-8,600
-17% -$2.84M 0.38% 34
2014
Q2
$16.4M Buy
52,100
+12,700
+32% +$3.82M 0.37% 30
2014
Q1
$12.1M Sell
39,400
-700
-2% -$222K 0.24% 61
2013
Q4
$11.2M Buy
40,100
+31,100
+346% +$8.04M 0.27% 50
2013
Q3
$2.17M Sell
9,000
-3,100
-26% -$694K 0.07% 302
2013
Q2
$2.6M Buy
+12,100
New +$2.59M 0.1% 238

Other funds holding BIIB

Twin Tree Management's BIIB Position: Q1 2026 in Review

Twin Tree Management reduced its Biogen (BIIB) stake by 94% in Q1 2026, selling an estimated $2.12M and leaving 759 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1132.

Twin Tree Management first reported a position in BIIB in Q2 2013 and has held it in 36 quarters since. The position peaked at $30.4M in Q3 2022. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Twin Tree Management held 759 shares of Biogen worth $139K as of Q1 2026.
  • Twin Tree Management sold 11,511 Biogen shares in Q1 2026, an estimated $2.12M.
  • Biogen made up ﹤0.01% of Twin Tree Management's portfolio in Q1 2026, its #1132 holding.
  • Twin Tree Management first reported a position in Biogen in Q2 2013 and has held it in 36 quarters since.
  • Twin Tree Management's Biogen position peaked at $30.4M in Q3 2022.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Twin Tree Management's 13F filing for Q1 2026, filed 14 May 2026.